ARK Investment Management LLC reduced its stake in Quantum-Si Incorporated (NASDAQ:QSI - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,713,501 shares of the company's stock after selling 135,149 shares during the period. ARK Investment Management LLC owned 4.76% of Quantum-Si worth $10,456,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of QSI. Bank of New York Mellon Corp raised its stake in Quantum-Si by 9.3% during the first quarter. Bank of New York Mellon Corp now owns 294,906 shares of the company's stock worth $354,000 after acquiring an additional 25,099 shares in the last quarter. EWA LLC acquired a new position in Quantum-Si during the first quarter worth about $94,000. WestHill Financial Advisors Inc. acquired a new position in Quantum-Si during the first quarter worth about $26,000. HBW Advisory Services LLC acquired a new position in Quantum-Si during the first quarter worth about $29,000. Finally, Green Alpha Advisors LLC raised its stake in Quantum-Si by 53.6% during the first quarter. Green Alpha Advisors LLC now owns 244,067 shares of the company's stock worth $293,000 after acquiring an additional 85,209 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on QSI. Alliance Global Partners reaffirmed a "buy" rating on shares of Quantum-Si in a research note on Friday, May 16th. HC Wainwright reaffirmed a "buy" rating and issued a $5.50 price objective on shares of Quantum-Si in a research note on Monday, May 19th.
Check Out Our Latest Analysis on Quantum-Si
Quantum-Si Stock Up 3.7%
NASDAQ:QSI traded up $0.06 during trading hours on Wednesday, hitting $1.70. 2,500,692 shares of the company traded hands, compared to its average volume of 12,146,423. The firm's 50-day simple moving average is $1.80 and its 200-day simple moving average is $1.63. Quantum-Si Incorporated has a one year low of $0.61 and a one year high of $5.77. The company has a market cap of $311.03 million, a PE ratio of -2.49 and a beta of 2.89.
Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.06. Quantum-Si had a negative return on equity of 41.44% and a negative net margin of 2,925.41%. The firm had revenue of $0.84 million during the quarter, compared to analyst estimates of $0.96 million. As a group, equities research analysts expect that Quantum-Si Incorporated will post -0.65 EPS for the current year.
Insider Transactions at Quantum-Si
In related news, CEO Jeffrey Alan Hawkins sold 23,705 shares of the business's stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total value of $38,165.05. Following the completion of the sale, the chief executive officer owned 2,623,011 shares in the company, valued at $4,223,047.71. The trade was a 0.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider John S. Vieceli sold 21,923 shares of the business's stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total value of $35,296.03. Following the completion of the sale, the insider owned 842,586 shares of the company's stock, valued at $1,356,563.46. The trade was a 2.54% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,252 shares of company stock valued at $87,346. Corporate insiders own 22.95% of the company's stock.
Quantum-Si Profile
(
Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Recommended Stories

Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.